30.61USD-5.64%Mkt Cap: 2.00B $P/E: —Today
Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company's lead product includes DMR-001, a investigational monoclona…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap2.00B $
Enterprise Value1.46B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-209.84M $
Revenue/Share—
Last Price30.61 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-14.15
PEG—
EV/EBITDA-15.19
EV/Revenue—
P/S—
P/B4.85
EPS (TTM)-0.26
EPS (Forward)-2.14
52W Range
30.810% of range33.56
52W High33.56 USD
52W Low30.81 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-87.29%
ROA-80.54%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.73M $
CapEx (TTM)—
FCF Margin—
FCF Yield-0.80%
Net Debt-540.52M $
Net Debt/EBITDA5.61
Balance Sheet
Debt/Equity0.00
Current Ratio19.73
Quick Ratio19.65
Book Value/Sh6.254 USD
Cash/Share8.755 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateAug 30, 2024
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)44.67 USD
Upside (mean)+45.9%
Target Range40.00 USD – 51.00 USD
$40.00+45.9% to mean$51.00
# Analysts9
Ownership
Shares Out.61.74M
Float41.40M
Insiders7.60%
Institutions105.63%
Short Interest
Short Ratio9.7d
Short % Float9.25%
Short % Out.7.93%
Shares Short4.89M
Short (prev mo.)3.57M
Technical
SMA 5027.90 (+9.7%)
SMA 20025.29 (+21.1%)
Beta1.48
S&P 52W Chg18.16%
Avg Vol (30d)420.83K
Avg Vol (10d)301.29K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—